drugset / Trial / NCT06145165

A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty

NCT06145165

RandomizedParallel-groupSingle-blindTreatment

Summary

To study the effectiveness of ACB and iPACK block with liposomal bupivacaine for postoperative analgesia in patients undergoing knee arthroplasty

Timeline

Start
2023-12-10
Primary completion
2024-12-31
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified Other
Subject Ropivacaine Other / unclassified Other
Background Sufentanil Other / unclassified 5 ug Intravenous

Indications

No indication recorded.